Regulatable gene expression systems for gene therapy applications: progress and future challenges.
about
Progresses towards safe and efficient gene therapy vectorsIntegrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potentialGene expression analysis in RA: towards personalized medicineHigh levels of the adhesion molecule CD44 on leukemic cells generate acute myeloid leukemia relapse after withdrawal of the initial transforming eventSpatial control of gene expression within a scaffold by localized inducer releaseLent-On-Plus Lentiviral vectors for conditional expression in human stem cellsThe appeasement of Doug: a synthetic approach to enhancer biology.'Nanodentistry': Exploring the beauty of miniature.Human gene therapy and imaging in neurological diseases.Synthetic tetracycline-inducible regulatory networks: computer-aided design of dynamic phenotypes.Characterization of a molecular switch system that regulates gene expression in mammalian cells through a small molecule.Separating lentiviral vector injection and induction of gene expression in time, does not prevent an immune response to rtTA in ratsA novel estrogen receptor intramolecular folding-based titratable transgene expression system.Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic virusesRegulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses.Enhancement of cell-specific transgene expression from a Tet-Off regulatory system using a transcriptional amplification strategy in the rat brainAdeno-associated virus-mediated doxycycline-regulatable TRAIL expression suppresses growth of human breast carcinoma in nude micePrevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin.HSV delivery of a ligand-regulated endogenous ion channel gene to sensory neurons results in pain control following channel activation.Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.Gene therapy and targeted toxins for glioma.Genetic control of wayward pluripotent stem cells and their progeny after transplantation.Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs.Anticancer activity of oncolytic adenovirus vector armed with IFN-alpha and ADP is enhanced by pharmacologically controlled expression of TRAILGene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.Targeted polymeric nanoparticles for cancer gene therapy.Synthetic riboswitches for external regulation of genes transferred by replication-deficient and oncolytic adenoviruses.Progress toward a nonviral gene therapy protocol for the treatment of anemia.Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cellsGenetics of Streptomyces rimosus, the oxytetracycline producer.Gene transfer for congestive heart failure: update 2013.The use of recombinant adeno-associated virus for skeletal gene therapy.Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaPolymeric nano- and microparticle technologies for oral gene delivery.Safeguarding clinical translation of pluripotent stem cells with suicide genes.Gene therapy for misfolding protein diseases of the central nervous system.Turning the gene tap off; implications of regulating gene expression for cancer therapeutics.The promise of gene therapy for the treatment of epilepsy.Preclinical Efficacy and Safety Profile of Allometrically Scaled Doses of Doxycycline Used to Turn "On" Therapeutic Transgene Expression from High-Capacity Adenoviral Vectors in a Glioma Model
P2860
Q26781432-E786C8A9-B9F3-4BCF-809A-5A4FC771A0D1Q26782613-D87B56BC-93B1-43F2-AE9F-95A222D00A9FQ26825706-F754AFA8-E7A8-45BF-8FAC-482E24AE33F2Q28299462-AAFDE495-5A9E-450C-A184-0E8883C71F75Q28304054-B531F873-AB16-42BA-8A00-E8F3F8EDB985Q28595666-03157206-F3DC-4332-9E61-05E3C8D41344Q30385188-B101AC4C-19FF-447B-828D-84F724EFE4C5Q30442809-3802B5E9-C2C6-4103-AC2C-7D8EB5CCAB0DQ31023442-8A6B7995-DE4A-44C8-9771-DECFFEA8BE26Q33281142-33C89495-9F4B-425D-90A0-932C9A367899Q33532286-514841DC-1221-4762-A67D-B788652382DCQ33550771-66EA6F3C-72D1-4C18-9406-2782E1467D32Q33713089-251189A7-CDD9-42FE-BB6D-DB63BD202B18Q33924550-C855DC71-1BE0-4D83-9955-5ABE23D77F9BQ34233124-0BC8B582-7E96-476B-9472-3CC79CC98362Q34233867-18DE0B06-93C0-419A-9022-36B24E14CC79Q34244279-A490799C-280F-4317-8783-1C1FCC2D65CBQ34556841-71B50A05-0C35-486F-A533-3C125D1E881CQ34621676-B0E73D1A-2BF4-41CA-9267-5B01FB8888CCQ35118919-24AA904B-AD39-4BB7-8F22-0F8E424F9047Q35118933-61D42726-A78C-4607-AB7F-9A7979276321Q35661899-D0972F7E-851F-42FE-8553-214BBDC3BFB3Q35870480-99F6FACF-FFC8-47AF-9189-44F488142EF8Q36169226-C3C0C5AC-BD41-4E22-AD56-7E728B5099B4Q36209190-4C2DC6A3-69AB-424A-BCD2-D8C65870BF55Q36384464-C4F482B7-4916-4DB2-895E-40C1836EFDA0Q36416427-E1B4E1FE-8F83-4DEC-88A7-FE48C39F55A0Q36422224-7746F22E-A111-4376-AAB9-D9A9FE3FA710Q36499510-91ED8E7C-43E5-491E-BE21-1FC3C3693B83Q36562321-051C4AB4-3C62-4DEE-8CAB-70789CE6641EQ36588777-4AC77FAB-F361-47D0-A7E4-F271621EA55EQ36698991-BC297EEC-3252-4F19-94BB-3F94107EED2DQ36729692-07AF2C1B-BDF1-47BB-8706-C961F9B99A2CQ36811505-9E9CDE62-F364-4176-95D2-C7F54CC173DEQ36815912-FBB61676-E9A8-48A4-8F8E-C72393412844Q36906143-CF4BDB12-D0FF-420B-8BC7-F7EFB18DB6CBQ36983203-4BED788F-310C-42E4-843D-6D76E0C36937Q36994041-7DE33777-2E80-4090-8BE7-4CFFE0E638C2Q37021317-AD81C1FD-B27E-4EDE-9466-1B545AA51A7FQ37050094-1E54E70F-9C26-4027-9EC5-F6F6802C3BE9
P2860
Regulatable gene expression systems for gene therapy applications: progress and future challenges.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Regulatable gene expression sy ...... rogress and future challenges.
@ast
Regulatable gene expression sy ...... rogress and future challenges.
@en
type
label
Regulatable gene expression sy ...... rogress and future challenges.
@ast
Regulatable gene expression sy ...... rogress and future challenges.
@en
prefLabel
Regulatable gene expression sy ...... rogress and future challenges.
@ast
Regulatable gene expression sy ...... rogress and future challenges.
@en
P2093
P2860
P1433
P1476
Regulatable gene expression sy ...... rogress and future challenges.
@en
P2093
D S Greengold
E B Soffer
J F Curtin
J M Zirger
M Candolfi
M G Castro
P2860
P304
P356
10.1016/J.YMTHE.2005.03.022
P577
2005-08-01T00:00:00Z